Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Direxion Daily S&P Biotech Bull 3X Shares (LABU)

Delayed Data
As of Jun 26
 -0.90 / -1.25%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index ("index"). The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments that provide daily leveraged exposure to the index and/or exchange-traded funds ("ETFs") that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.

5 Reasons Why Biotech ETFs are Soaring
Jun 22 / Zacks.com - Paid Partner Content
4 Stocks & ETFs to Buy on Clovis' Positive Drug Data
Jun 21 / Zacks.com - Paid Partner Content


1 month+51.68% 3 years--
3 months+58.80% 5 years--
1 year+140.70% Since inception-31.93%
Data through 06/24/2017

Quote Details

Previous close$71.90
Open day’s range68.64 – 73.07
Net asset value (NAV)71.73 (06/23/2017)
Daily volume2,055,901
Average volume (3 months)1,700,253
Data as of 7:59pm ET, 06/26/2017

Peer Comparisonvs. Trading--leveraged equity ETFs

Performance 5-yr return--+16.48%
Expense Gross exp ratio1.11%2.02%
Risk 5 year sharpe ratio----
Net assets$267.9M$65.1M
Average market cap$5.0B--
Average P/E----
Dividend / Share--0.31%


No competitors data available.


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
-- 23.09%
-- 13.61%
-- 7.06%
XBI SPDR® S&P Biotech ETF4.20%
-- 3.24%
-- 2.87%
-- 1.81%
-- 1.71%
-- 1.45%